• Beating psoriasis • Dyson launches humidifier to combat eczema and psoriasis Half the participants were given the new drug, ixekizumab while the other half were given a placebo, or a widely used drug for psoriasis called etanercept.
The ixekizumab groups showed quick and extensive improvements in their condition, outperforming the groups on placebo or etanercept.
LUNCHTIME trade was thrown into chaos at Northway Plaza after a car crashed through the glass walls of a popular cafe yesterday.
Nobody is more open about their love for strippers than Drake."What we saw in this trial was not just the physical aspects of the disease clearing up, but people on the new drug also reporting a marked improvement in their quality of life as they felt more confident and suffered less from itching - far more than in the other two groups." Current treatments range from topical creams and shampoos, through to Ultra-Violet light therapy, tablets and injections.However, different cases respond to different treatments and sufferers can often spend a long time experimenting through trial-and-error.The trial drug Ixekizumab is a cloned antibody, which neutralises the inflammatory effects of an interleukin, a protein in the skin which carries signals to cells.This particular protein is increasingly becoming recognised as one of the causes of psoriasis.The study, conducted at the University of Manchester, tested the effectiveness of the drug ixekizumab.